Impact of the COVID-19 pandemic on the prevalence of respiratory viral pathogens in patients with acute respiratory infection in Shanghai, ChinaPublic Health Original Research Published on 2024-02-072024-09-05 Journal: Frontiers in public health [Category] update2024, [키워드] Acute respiratory infection COVID-19 Nonpharmaceutical interventions Shanghai viral pathogen [DOI] 10.3389/fpubh.2024.1230139 PMC 바로가기 [Article Type] Public Health Original Research
1920-30년대 중국의 두창 방역과 공공의료 : 상하이와 베이징의 사례를 중심으로 †Article Published on 2023-08-312024-09-05 Journal: Ŭi sahak [Category] update2024, [키워드] Beijing Health Demonstration Station Public healthcare Shanghai smallpox state medicine 공공의료 국가의료 두창 베이징 상하이 위생구사무소 [DOI] 10.13081/kjmh.2023.32.727 PMC 바로가기 [Article Type] Article
Epidemiological characteristics of paediatric Omicron infection during the outbreak of SARS-CoV-2 infection during March–May in 2022 in Shanghai, Chinaarticle Published on 2023-05-052024-09-05 Journal: Epidemiology and Infection [Category] update2024, [키워드] children Epidemiological characteristics Omicron variant SARS-CoV-2 Shanghai [DOI] 10.1017/S0950268823000663 PMC 바로가기 [Article Type] article
Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022article Published on 2023-01-312024-09-01 Journal: Emerging Infectious Diseases [Category] 백일해, [키워드] antimicrobial resistance Bacteria Bordetella pertussis China Genotype Macrolide Shanghai vaccine-preventable diseases [Article Type] article
Spatiotemporal pattern recognition and dynamical analysis of COVID-19 in Shanghai, ChinaArticle Published on 2022-12-072022-11-15 Journal: Journal of theoretical biology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Analysis Autocorrelation analysis China COVID-19 COVID-19 disease Daily Daily reproduction number diffusion disease dissemination dynamic Dynamic model early stage Effect hotspot IMPROVE mutant omicron outbreak provided retrospective SARS-CoV-2 transmission Shanghai Spatial statistics. spatiotemporal statistical suffered suppress the epidemic [DOI] 10.1016/j.jtbi.2022.111279 PMC 바로가기
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialArticle Published on 2022-12-012022-10-06 Journal: The Lancet Regional Health - Western Pacific [Category] 진단, [키워드] acute respiratory syndrome Administered Adults adverse event AEs age Analysis assessment assigned BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine China Chinese clinical trial Complete Completed conducted coronavirus COVID-19 development dose double-blind Efficacy and safety enrolled Follow-up geometric mean titer GMT GMTs Han Chinese healthy immune response immunogenicity immunogenicity endpoint Inc independent individual injection intramuscular Intramuscular injection investigators Laboratory parameters management messenger Messenger RNA Mild moderate mRNA vaccine Neutralising Antibodies neutralising antibody of BNT162b2 participant Participants pharmaceutical Placebo placebo-controlled trial randomisation randomised Randomly reactogenicity receive recipients recruited reduced remained reported resolved Result robust Safety SARS-CoV-2 SARS-CoV-2 variant SCR second dose sera serious AE seroconversion rate severity Shanghai Sponsor statisticians stratified T-cell Response the placebo group Tolerability Treatment Trial utilised vaccination vaccine administration were blinded [DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article
Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccinationArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] Anti-spike Antibody Response B cell B cell responses BBIBP-CorV booster booster vaccination CD4 CD8 comparable COVID-19 COVID-19 vaccines de novo demonstrated detectable dramatic increase Epidemic exhibited Features humoral immune response Humoral immunity humoral responses interferon-γ Neutralizing antibodies omicron remained S protein SARS-CoV-2 SARS-COV-2 infection serotype Severe case Shanghai significantly T cell T cell response T cell responses T cell responses. Th1 cytokine vaccination vaccinee vaccinees wild type [DOI] 10.1080/22221751.2022.2130101 PMC 바로가기
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022Article Published on 2022-12-012023-07-10 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), [키워드] Clinical severity COVID-19 disease burden. Omicron BA.2 Shanghai [DOI] 10.1080/22221751.2022.2128435 PMC 바로가기
Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort studyArticle Published on 2022-12-012022-11-16 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 치료기술, [키워드] advanced age age Cancer China Chronic kidney disease CKD cohort study Comorbidity condition conditions COVID-19 critical cases enrolled Factor female first positive hospialized population Hospitalized hospitalized patient hypertension identification Logistic regression Metabolic disorders multivariate Observational cohort study omicron participant Patient patients Primary outcome Prognosis progression risk factor Risk factors SARS-CoV-2 SARS-CoV-2 detection secondary outcome severity Shanghai suggested vaccination viral shedding [DOI] 10.1080/22221751.2022.2122581 PMC 바로가기
Clinical and virological characteristics of SARS-CoV-2 Omicron BA.2.2 variant outbreaks during April to May, 2022, Shanghai, ChinaArticle Published on 2022-11-012022-11-16 Journal: The Journal of Infection [Category] SARS, 변종, [키워드] Characteristics China clinical omicron outbreak SARS-CoV-2 Shanghai variant Virological [DOI] 10.1016/j.jinf.2022.07.027 PMC 바로가기